vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and OPPENHEIMER HOLDINGS INC (OPY). Click either name above to swap in a different company.

OPPENHEIMER HOLDINGS INC is the larger business by last-quarter revenue ($472.6M vs $292.2M, roughly 1.6× Cellebrite DI Ltd.). OPPENHEIMER HOLDINGS INC runs the higher net margin — 15.7% vs -103.5%, a 119.2% gap on every dollar of revenue. OPPENHEIMER HOLDINGS INC produced more free cash flow last quarter ($183.6M vs $60.8M). Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs 15.7%).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

Oppenheimer Holdings Inc. is an American multinational independent investment bank and financial services company offering investment banking, financial advisory services, capital markets services, asset management, wealth management, and related products and services worldwide. The company, which once occupied the One World Financial Center building in Manhattan, now bases its operations at 85 Broad Street in New York City.

CLBT vs OPY — Head-to-Head

Bigger by revenue
OPY
OPY
1.6× larger
OPY
$472.6M
$292.2M
CLBT
Higher net margin
OPY
OPY
119.2% more per $
OPY
15.7%
-103.5%
CLBT
More free cash flow
OPY
OPY
$122.7M more FCF
OPY
$183.6M
$60.8M
CLBT
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
15.7%
OPY

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CLBT
CLBT
OPY
OPY
Revenue
$292.2M
$472.6M
Net Profit
$-302.3M
$74.4M
Gross Margin
84.6%
Operating Margin
14.1%
22.4%
Net Margin
-103.5%
15.7%
Revenue YoY
25.9%
Net Profit YoY
593.1%
EPS (diluted)
$-1.50
$6.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
OPY
OPY
Q4 25
$472.6M
Q3 25
$292.2M
$424.4M
Q2 25
$220.8M
$373.2M
Q1 25
$89.6M
$367.8M
Q4 24
$375.4M
Q3 24
$232.1M
$373.4M
Q2 24
$185.3M
$330.6M
Q1 24
$71.2M
$353.1M
Net Profit
CLBT
CLBT
OPY
OPY
Q4 25
$74.4M
Q3 25
$-302.3M
$21.7M
Q2 25
$36.9M
$21.7M
Q1 25
$-71.4M
$30.7M
Q4 24
$10.7M
Q3 24
$24.5M
Q2 24
$-95.2M
$10.3M
Q1 24
$-40.6M
$26.1M
Gross Margin
CLBT
CLBT
OPY
OPY
Q4 25
Q3 25
84.6%
Q2 25
84.1%
Q1 25
85.2%
Q4 24
Q3 24
83.5%
Q2 24
84.1%
Q1 24
82.6%
Operating Margin
CLBT
CLBT
OPY
OPY
Q4 25
22.4%
Q3 25
14.1%
7.5%
Q2 25
12.1%
8.6%
Q1 25
10.3%
11.2%
Q4 24
4.5%
Q3 24
7.9%
9.5%
Q2 24
11.7%
4.8%
Q1 24
0.2%
10.6%
Net Margin
CLBT
CLBT
OPY
OPY
Q4 25
15.7%
Q3 25
-103.5%
5.1%
Q2 25
16.7%
5.8%
Q1 25
-79.7%
8.3%
Q4 24
2.9%
Q3 24
6.6%
Q2 24
-51.4%
3.1%
Q1 24
-57.0%
7.4%
EPS (diluted)
CLBT
CLBT
OPY
OPY
Q4 25
$6.51
Q3 25
$-1.50
$1.90
Q2 25
$0.15
$1.91
Q1 25
$-0.36
$2.72
Q4 24
$0.92
Q3 24
$-0.35
$2.16
Q2 24
$-0.48
$0.92
Q1 24
$-0.21
$2.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
OPY
OPY
Cash + ST InvestmentsLiquidity on hand
$191.7M
$38.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$336.0M
$983.8M
Total Assets
$690.6M
$3.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
OPY
OPY
Q4 25
$38.4M
Q3 25
$191.7M
$38.3M
Q2 25
$326.1M
$37.6M
Q1 25
$191.7M
$36.7M
Q4 24
$33.1M
Q3 24
$189.5M
$32.2M
Q2 24
$178.6M
$33.2M
Q1 24
$189.5M
$27.7M
Total Debt
CLBT
CLBT
OPY
OPY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
$112.8M
Q2 24
$112.8M
Q1 24
$112.7M
Stockholders' Equity
CLBT
CLBT
OPY
OPY
Q4 25
$983.8M
Q3 25
$336.0M
$920.3M
Q2 25
$408.4M
$896.9M
Q1 25
$336.0M
$872.3M
Q4 24
$850.4M
Q3 24
$34.2M
$837.8M
Q2 24
$-40.2M
$812.1M
Q1 24
$34.2M
$801.5M
Total Assets
CLBT
CLBT
OPY
OPY
Q4 25
$3.7B
Q3 25
$690.6M
$3.8B
Q2 25
$787.4M
$3.7B
Q1 25
$690.6M
$3.6B
Q4 24
$3.4B
Q3 24
$532.9M
$3.4B
Q2 24
$556.6M
$3.3B
Q1 24
$532.9M
$3.3B
Debt / Equity
CLBT
CLBT
OPY
OPY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
OPY
OPY
Operating Cash FlowLast quarter
$66.2M
$188.8M
Free Cash FlowOCF − Capex
$60.8M
$183.6M
FCF MarginFCF / Revenue
20.8%
38.8%
Capex IntensityCapex / Revenue
1.8%
1.1%
Cash ConversionOCF / Net Profit
2.54×
TTM Free Cash FlowTrailing 4 quarters
$172.1M
$191.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
OPY
OPY
Q4 25
$188.8M
Q3 25
$66.2M
$63.4M
Q2 25
$53.5M
$40.1M
Q1 25
$10.0M
$-91.7M
Q4 24
$-108.2M
Q3 24
$58.2M
$11.4M
Q2 24
$24.6M
$-115.3M
Q1 24
$12.5M
$-79.0M
Free Cash Flow
CLBT
CLBT
OPY
OPY
Q4 25
$183.6M
Q3 25
$60.8M
$62.2M
Q2 25
$47.5M
$38.9M
Q1 25
$8.5M
$-93.4M
Q4 24
$-113.3M
Q3 24
$55.3M
$11.2M
Q2 24
$21.0M
$-116.7M
Q1 24
$11.4M
$-79.3M
FCF Margin
CLBT
CLBT
OPY
OPY
Q4 25
38.8%
Q3 25
20.8%
14.7%
Q2 25
21.5%
10.4%
Q1 25
9.5%
-25.4%
Q4 24
-30.2%
Q3 24
23.8%
3.0%
Q2 24
11.3%
-35.3%
Q1 24
16.0%
-22.5%
Capex Intensity
CLBT
CLBT
OPY
OPY
Q4 25
1.1%
Q3 25
1.8%
0.3%
Q2 25
2.7%
0.3%
Q1 25
1.7%
0.5%
Q4 24
1.4%
Q3 24
1.3%
0.1%
Q2 24
1.9%
0.4%
Q1 24
1.5%
0.1%
Cash Conversion
CLBT
CLBT
OPY
OPY
Q4 25
2.54×
Q3 25
2.92×
Q2 25
1.45×
1.85×
Q1 25
-2.99×
Q4 24
-10.08×
Q3 24
0.47×
Q2 24
-11.23×
Q1 24
-3.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

OPY
OPY

Advisory Fees$166.6M35%
Capital Markets Segment$155.5M33%
Other$57.2M12%
Commissions From Sales And Trading$52.9M11%
Bank Deposit Sweep Income$27.7M6%
Mutual Fund Income$8.9M2%
Investment Banking Capital Markets$3.3M1%

Related Comparisons